Literature DB >> 24953530

B cell follicle-like structures in multiple sclerosis-with focus on the role of B cell activating factor.

Morten Haugen1, Jette L Frederiksen2, Matilda Degn3.   

Abstract

B lymphocytes play an important role in the pathogenesis of multiple sclerosis (MS). Follicle-like structures (FLS) have recently been found in the subarachnoid space in the leptomeninges in some patients with secondary progressive MS (SPMS). They contain proliferating B lymphocytes, plasma cells, helper T lymphocytes and a network of follicular dendritic cells. FLS have been shown to correlate with increased cortical demyelination, neuronal loss, meningeal infiltration and central nervous system inflammation, as well as lower age at disease onset and progression to severe disability and death. In this review, we will discuss the role of FLS in MS pathogenesis and disease course and the possible influence by B cell activating factor (BAFF) and C-X-C motif chemokine 13 (CXCL13).
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cell activating factor; B lymphocytes; Follicle-like structures; Meningeal inflammation; Multiple sclerosis

Mesh:

Substances:

Year:  2014        PMID: 24953530     DOI: 10.1016/j.jneuroim.2014.05.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

Review 1.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

2.  Targeting CXCL13 During Neuroinflammation.

Authors:  Amanda K Huber; David N Irani
Journal:  Adv Neuroimmune Biol       Date:  2015-11-13

3.  Imaging B Cells in a Mouse Model of Multiple Sclerosis Using 64Cu-Rituximab PET.

Authors:  Michelle L James; Aileen Hoehne; Aaron T Mayer; Kendra Lechtenberg; Monica Moreno; Gayatri Gowrishankar; Ohad Ilovich; Arutselvan Natarajan; Emily M Johnson; Joujou Nguyen; Lisa Quach; May Han; Marion Buckwalter; Sudeep Chandra; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2017-07-07       Impact factor: 10.057

4.  B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue.

Authors:  Klaus Lehmann-Horn; Sheng-Zhi Wang; Sharon A Sagan; Scott S Zamvil; H-Christian von Büdingen
Journal:  JCI Insight       Date:  2016-12-08

5.  No Early Effect of Intrathecal Rituximab in Progressive Multiple Sclerosis (EFFRITE Clinical Trial).

Authors:  Mickael Bonnan; Sylvie Ferrari; Henri Courtade; Paul Money; Pauline Desblache; Bruno Barroso; Stéphane Debeugny
Journal:  Mult Scler Int       Date:  2021-03-08

Review 6.  B Cells and Autoantibodies in Multiple Sclerosis.

Authors:  Anne-Katrin Pröbstel; Nicholas S R Sanderson; Tobias Derfuss
Journal:  Int J Mol Sci       Date:  2015-07-21       Impact factor: 5.923

Review 7.  Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.

Authors:  Mickael Bonnan
Journal:  Mult Scler Int       Date:  2015-01-08

8.  Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune Disease.

Authors:  Amy K Dang; Yodit Tesfagiorgis; Rajiv W Jain; Heather C Craig; Steven M Kerfoot
Journal:  Front Immunol       Date:  2015-09-15       Impact factor: 7.561

Review 9.  Hypersensitivity Responses in the Central Nervous System.

Authors:  Reza Khorooshi; Nasrin Asgari; Marlene Thorsen Mørch; Carsten Tue Berg; Trevor Owens
Journal:  Front Immunol       Date:  2015-10-07       Impact factor: 7.561

10.  Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines.

Authors:  Renuka Natarajan; Sanna Hagman; Mari Hämälainen; Tiina Leppänen; Prasun Dastidar; Eeva Moilanen; Irina Elovaara
Journal:  Mult Scler Int       Date:  2015-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.